Related Experiment Videos
Danazol and limb-threatening arterial thrombosis: two case reports
R G Alvarado1, J Y Liu, R M Zwolak
1Dartmouth Medical School, Lebanon, NH, USA.
Journal of Vascular Surgery
|December 18, 2001
Summary
Danazol, a synthetic androgenic steroid, may increase the risk of arterial thrombosis. This study reports two new cases of limb-threatening arterial thrombosis in patients treated with danazol.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Pharmacology
Background:
- Danazol is a synthetic androgenic steroid used to treat various medical conditions.
- While androgens are not extensively proven to cause thrombosis in humans, anabolic-androgenic steroid abuse is linked to arterial thrombosis.
- Previous reports indicate potential thrombotic events associated with danazol therapy.
Observation:
- Two new cases of limb-threatening arterial thrombosis were observed in patients receiving danazol.
- These events occurred in patients undergoing danazol treatment for unspecified disorders.
Findings:
- The observed cases suggest a potential link between danazol therapy and the development of arterial thrombosis.
- The data points to danazol as a possible independent risk factor for arterial thrombotic events.
Implications:
- Clinicians should consider the potential thrombogenic risk of danazol, especially in susceptible individuals.
- Further research is warranted to confirm danazol's role as an independent risk factor for arterial thrombosis.
- This finding may influence clinical guidelines regarding danazol use and patient monitoring.